Monday, September 18, 2017 3:47:16 PM
Shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) ran from $15.00 to $20.00 in two days, just over a week ago. Since then, the stock has gradually pulled back. This price action is known as consolidation and an inside-bar bullish setup. The inside-bar bullish setup is almost complete with Teva Pharmaceutical Industries kissing the daily 20 moving average at $16.75. This is where it should begin to form some sort of base and begin its next leg up. I am very bullish on Teva Pharmaceutical Industries, especially after they landed a new CEO and saw some analyst upgrades. I believe the stock will see $25 by early 2018.
Gareth Soloway
InTheMoneyStocks
Recent TEVA News
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
